Black patients more likely to be excluded from pancreatic cancer clinical trials

An unusual phenotype occurs in 15% of mismatch repair-deficient

Imaging criteria helps pick best patients for Pluvicto treatment

Utility of circulating tumor DNA for predicting prognosis in the

Is treatment in certified cancer centers related to better

Impact of saturated compared with unsaturated dietary fat on

Impact of chemoradiotherapy on the survival of unresectable

SOM Discoveries 2022 VCU School of Medicine

Postresection CA19-9 and margin status as predictors of recurrence

Racial Disparities in Cancer Outcomes, Screening, and Treatment

Prolonged time to treatment initiation in advanced pancreatic

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

Efficacy and safety of neoadjuvant sintilimab, oxaliplatin and

Frontiers Can Elderly Patients With Pancreatic Cancer Gain

Distinct Survival Outcomes in Subgroups of Stage III Pancreatic